These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6230454)

  • 1. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced suppressor cell activity in intestinal lymphocytes from patients with Crohn's disease.
    Goodacre RL; Bienenstock J
    Gastroenterology; 1982 Apr; 82(4):653-8. PubMed ID: 7060886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
    Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
    Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
    Holdstock G; Chastenay BF; Krawitt EL
    Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
    Holdstock G; Chastenay BF; Krawitt EL
    Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covert suppressor T cells in Crohn's disease.
    Elson CO; Graeff AS; James SP; Strober W
    Gastroenterology; 1981 Jun; 80(6):1513-21. PubMed ID: 6453036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
    Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
    Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
    Minassian AA; Kadagidze ZG
    Neoplasma; 1983; 30(2):153-8. PubMed ID: 6221196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
    Braun DP; Penn RD; Flannery AM; Harris JE
    Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of the serum immunosuppressive factor by monocytes in patients with Crohn's disease.
    Watanabe M; Hibi T; Iwao Y; Kanai T; Ohara M; Fujisawa T; Ogata H; Watanabe N; Asakura H; Aiso S
    J Clin Lab Immunol; 1989 Aug; 29(4):161-6. PubMed ID: 2637362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation of the major omentum-associated lymphoid tissue in Crohn disease].
    Schreiber S; Gehrckens A; Raedler A
    Zentralbl Chir; 1995; 120(2):135-44. PubMed ID: 7709665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic response and interleukin 2 production in Crohn's disease.
    Miura M; Hiwatashi N
    J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological suppressor cell activity in insulin dependent diabetes.
    Slater LM; Murray SL; Kershnar A; Mosier MA
    J Clin Lab Immunol; 1980 Mar; 3(2):105-9. PubMed ID: 6451707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [T-lymphocyte subpopulations in the peripheral blood of patients with Crohn disease].
    Purrmann J; Hengels KJ; Cleveland S; Gemsa R; Koldehoff M; Strohmeyer G
    Z Gastroenterol; 1990 May; 28(5):242-6. PubMed ID: 2144933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
    Braun DP; Harris JE
    J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of cell-mediated immunity in patients with Crohn's disease.
    Surrenti C; Ramarli D; Casini A; Scartabelli S; Campi P; Fani A; Nieri S
    Hepatogastroenterology; 1981 Jun; 28(3):157-9. PubMed ID: 7250897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune dysfunction in primary biliary cirrhosis (PBC): I. Increased sensitivity of PHA stimulated lymphocyte cultures to indomethacin.
    Licastro F; Lenzi M; Chiricolo M; Davis LJ; Cassani F; Bianchi F; Franceschi C
    J Clin Lab Immunol; 1987 May; 23(1):19-23. PubMed ID: 3612758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
    Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
    J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.